These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28468864)
1. Nodal Signaling as a Developmental Therapeutics Target in Oncology. Kalyan A; Carneiro BA; Chandra S; Kaplan J; Chae YK; Matsangou M; Hendrix MJC; Giles F Mol Cancer Ther; 2017 May; 16(5):787-792. PubMed ID: 28468864 [TBL] [Abstract][Full Text] [Related]
2. Expression of Nodal, Cripto, SMAD3, phosphorylated SMAD3, and SMAD4 in the proliferative endometrium of women with endometriosis. Cruz CD; Del Puerto HL; Rocha AL; Cavallo IK; Clarizia AD; Petraglia F; Reis FM Reprod Sci; 2015 May; 22(5):527-33. PubMed ID: 25228630 [TBL] [Abstract][Full Text] [Related]
3. Expression of nodal signalling components in cycling human endometrium and in endometrial cancer. Papageorgiou I; Nicholls PK; Wang F; Lackmann M; Makanji Y; Salamonsen LA; Robertson DM; Harrison CA Reprod Biol Endocrinol; 2009 Oct; 7():122. PubMed ID: 19874624 [TBL] [Abstract][Full Text] [Related]
4. NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway. Sun C; Sun L; Jiang K; Gao DM; Kang XN; Wang C; Zhang S; Huang S; Qin X; Li Y; Liu YK Int J Biochem Cell Biol; 2013 Jun; 45(6):1099-108. PubMed ID: 23474366 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of Nodal correlates with reduced patient survival in pancreatic cancer. Kong B; Wang W; Esposito I; Friess H; Michalski CW; Kleeff J Pancreatology; 2015; 15(2):156-61. PubMed ID: 25708930 [TBL] [Abstract][Full Text] [Related]
6. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455 [TBL] [Abstract][Full Text] [Related]
7. Designer nodal/BMP2 chimeras mimic nodal signaling, promote chondrogenesis, and reveal a BMP2-like structure. Esquivies L; Blackler A; Peran M; Rodriguez-Esteban C; Izpisua Belmonte JC; Booker E; Gray PC; Ahn C; Kwiatkowski W; Choe S J Biol Chem; 2014 Jan; 289(3):1788-97. PubMed ID: 24311780 [TBL] [Abstract][Full Text] [Related]
8. A Temporal Window for Signal Activation Dictates the Dimensions of a Nodal Signaling Domain. van Boxtel AL; Chesebro JE; Heliot C; Ramel MC; Stone RK; Hill CS Dev Cell; 2015 Oct; 35(2):175-85. PubMed ID: 26506307 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway. Duan W; Li R; Ma J; Lei J; Xu Q; Jiang Z; Nan L; Li X; Wang Z; Huo X; Han L; Wu Z; Wu E; Ma Q Oncotarget; 2015 Jan; 6(3):1490-506. PubMed ID: 25557170 [TBL] [Abstract][Full Text] [Related]
10. Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways. Sun G; Shi L; Li M; Jiang N; Fu L; Guo J J Neurol Sci; 2014 Dec; 347(1-2):137-42. PubMed ID: 25304053 [TBL] [Abstract][Full Text] [Related]
11. Role of Cripto-1 in stem cell maintenance and malignant progression. Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Sakuma R; Ohnishi Yi Y; Meno C; Fujii H; Juan H; Takeuchi J; Ogura T; Li E; Miyazono K; Hamada H Genes Cells; 2002 Apr; 7(4):401-12. PubMed ID: 11952836 [TBL] [Abstract][Full Text] [Related]
13. Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma. Matsumoto T; Chino H; Akiya M; Hashimura M; Yokoi A; Tochimoto M; Nakagawa M; Jiang Z; Saegusa M Mol Carcinog; 2020 Dec; 59(12):1409-1419. PubMed ID: 33111989 [TBL] [Abstract][Full Text] [Related]
14. TGFβ signaling in establishing left-right asymmetry. Shiratori H; Hamada H Semin Cell Dev Biol; 2014 Aug; 32():80-4. PubMed ID: 24704359 [TBL] [Abstract][Full Text] [Related]
15. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers. Sandomenico A; Ruvo M Curr Med Chem; 2019; 26(11):1994-2050. PubMed ID: 30207211 [TBL] [Abstract][Full Text] [Related]
16. E2A regulates neural ectoderm fate specification in human embryonic stem cells. Yi S; Huang X; Zhou S; Zhou Y; Anderson MK; Zúñiga-Pflücker JC; Luan Q; Li Y Development; 2020 Dec; 147(23):. PubMed ID: 33144398 [TBL] [Abstract][Full Text] [Related]
17. Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway. Gong W; Sun B; Zhao X; Zhang D; Sun J; Liu T; Gu Q; Dong X; Liu F; Wang Y; Lin X; Li Y Oncotarget; 2016 Oct; 7(43):70152-70167. PubMed ID: 27659524 [TBL] [Abstract][Full Text] [Related]
18. New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates. Arboretto P; Cillo M; Leonardi A Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360603 [TBL] [Abstract][Full Text] [Related]
19. New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding. Focà A; Sanguigno L; Focà G; Strizzi L; Iannitti R; Palumbo R; Hendrix MJ; Leonardi A; Ruvo M; Sandomenico A Int J Mol Sci; 2015 Sep; 16(9):21342-62. PubMed ID: 26370966 [TBL] [Abstract][Full Text] [Related]
20. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model. Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]